Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Young women with PCOS without additional risk factors may have normal heart function.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.